Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of CRx-102 in Subjects With Symptomatic Knee Osteoarthritis and Optional One-Year Extension

NCT00521989 is registered in ClinicalTrials.gov with Zalicus as lead sponsor.

NCT NCT00521989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00521989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of CRx-102 in Subjects With Symptomatic Knee Osteoarthritis and Optional One-Year Extension
Lead sponsor
Zalicus
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2007
Completion date
July 31, 2009
Enrollment
279 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis